Filter News
Area of Research
- (-) Neutron Science (5)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (2)
- Biology and Environment (5)
- Clean Energy (12)
- Computational Engineering (1)
- Computer Science (4)
- Fusion Energy (8)
- Materials (5)
- Materials for Computing (2)
- National Security (3)
- Quantum information Science (1)
- Supercomputing (10)
News Topics
- (-) Biomedical (7)
- (-) Fusion (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (6)
- Bioenergy (4)
- Climate Change (1)
- Composites (1)
- Computer Science (5)
- Coronavirus (3)
- Decarbonization (1)
- Energy Storage (1)
- Environment (3)
- Isotopes (3)
- Materials Science (8)
- Microscopy (2)
- Molten Salt (3)
- Nanotechnology (5)
- National Security (1)
- Neutron Science (35)
- Nuclear Energy (16)
- Physics (5)
- Quantum Science (3)
- Space Exploration (3)
- Summit (4)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Juergen Rapp, a distinguished R&D staff scientist in ORNL’s Fusion Energy Division in the Nuclear Science and Engineering Directorate, has been named a fellow of the American Nuclear Society
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
As scientists study approaches to best sustain a fusion reactor, a team led by Oak Ridge National Laboratory investigated injecting shattered argon pellets into a super-hot plasma, when needed, to protect the reactor’s interior wall from high-energy runaway electrons.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
As the rise of antibiotic-resistant bacteria known as superbugs threatens public health, Oak Ridge National Laboratory’s Shuo Qian and Veerendra Sharma from the Bhaba Atomic Research Centre in India are using neutron scattering to study how an antibacterial peptide interacts with and fights harmful bacteria.
A team of scientists, led by University of Guelph professor John Dutcher, are using neutrons at ORNL’s Spallation Neutron Source to unlock the secrets of natural nanoparticles that could be used to improve medicines.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.